bioAffinity Technologies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 64%.

Top 25 shareholders own 34.28% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.2%	Harvey Sandler	1,584,144	US$2.0m	0%	no data
6.89%	Steven Girgenti	1,074,106	US$1.3m	0%	no data
4.17%	Roby Joyce	649,745	US$802.4k	0%	no data
2.1%	Nathan Perlmutter	327,909	US$405.0k	0%	no data
1.67%	The Vanguard Group, Inc.	260,869	US$322.2k	51.7%	no data
1.56%	Maria Zannes	243,322	US$300.5k	0%	no data
1.05%	Robert Anderson	163,936	US$202.5k	0%	no data
0.94%	Gary Rubin	146,597	US$181.0k	0%	no data
0.75%	Peter Knight	117,455	US$145.1k	0%	no data
0.73%	J. Edwards	113,956	US$140.7k	717%	no data
0.7%	Mohsin Meghji	109,737	US$135.5k	0%	no data
0.64%	Stuart Diamond	99,088	US$122.4k	0%	no data
0.56%	Geode Capital Management, LLC	87,181	US$107.7k	25.3%	no data
0.54%	Michael Dougherty	84,203	US$104.0k	0%	no data
0.35%	Jamie Platt	54,748	US$67.6k	0%	no data
0.3%	Vivienne Rebel	46,228	US$57.1k	0%	no data
0.3%	Timothy Zannes	46,124	US$57.0k	0%	no data
0.18%	CapFinancial Partners, LLC, Asset Management Arm	27,885	US$34.4k	0%	no data
0.13%	Xavier Reveles	20,339	US$25.1k	0%	no data
0.13%	Sheaff Brock Investment Advisors, LLC	20,000	US$24.7k	33.3%	no data
0.11%	State Street Global Advisors, Inc.	17,600	US$21.7k	0%	no data
0.088%	Northern Trust Global Investments	13,662	US$16.9k	0%	no data
0.078%	Creative Planning, LLC	12,095	US$14.9k	-3.97%	no data
0.072%	XTX Holdings Limited, Asset Management Arm	11,264	US$13.9k	0%	no data
0.064%	IFP Advisors, LLC	10,000	US$12.4k	0%	no data